Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Mayne Pharma Group Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

06 Feb 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Mayne Pharma Group Ltd (MYX-AU)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

12 Feb 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Mayne Pharma Group Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

31 Jan 2016 Wright Reports 55 $75.00

Mayne Pharma Group Limited (MYX) - Financial Analysis Review

Mayne Pharma Group Limited (MYX) - Financial Analysis Review Summary Mayne Pharma Group Limited (Mayne Pharma) is a pharmaceu...

22 Jan 2016 GlobalData 67 $300.00

Mayne Pharma Group Limited (MYX) - Financial Analysis Review

Mayne Pharma Group Limited (MYX) - Financial Analysis Review Summary Mayne Pharma Group Limited (Mayne Pharma) is a pharmaceu...

15 Dec 2015 GlobalData 70 $300.00

Is Mayne Pharma Group Ltd Worth a Higher Bid?

27 Nov 2015 Sadif Analytics Prime 12 $25.00

Mayne Pharma Group Ltd: Upgraded to Average

10 Sep 2015 Sadif Analytics Prime 3 $10.00

Mayne Pharma Group Limited

Mayne Pharma is an ASX-listed specialty pharmaceutical company that develops and manufactures branded and generic products, ...

07 Sep 2015 Acquisdata 12 $15.00

Company Snapshot - Mayne Pharma Group Limited

A director at Mayne Pharma Group Limited bought 680,000 shares at 1.096AUD and the significance rating of the trade was 67/10...

07 Sep 2015 Directors Deals Ltd. 1 $12.00

Will Mayne Pharma Group Ltd Deliver Long-Term Returns?

26 Aug 2015 Sadif Analytics Prime 12 $25.00